Pharmaceutical Patents on Manufacturing Methods: Groundless or Well-Supported?
Are manufacturing method patents warranted intellectual property protections, or groundless obstacles to competition?
Intellectual Property
-
Read more: Pharmaceutical Patents on Manufacturing Methods: Groundless or Well-Supported? -
Read more: When “Pay-for-Delay” Becomes “Delay-Without-Pay”: Humira Antitrust Claims When “Pay-for-Delay” Becomes “Delay-Without-Pay”: Humira Antitrust Claims
In this post, I explore several problematic aspects of the court’s reasoning for rejecting the claims of pay-for-delay and market allocation.
-
Read more: Year in Review: Biosimilars Year in Review: Biosimilars
In November 2020, the FDA released its most recent draft guidance for industry on biosimilarity and interchangeability
-
Read more: Clash of Titans? A Brewing Dispute between Telehealth Giants Clash of Titans? A Brewing Dispute between Telehealth Giants
Competition between telehealth providers spilled into open conflict last month, as incumbent Teladoc filed a patent infringement suit against Amwell.
-
Read more: Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check
To secure widespread access to a COVID-19 vaccine, many countries plan to seek refuge in a long-existing strategy: compulsory licensing.
-
Read more: Deconstructing Moderna’s COVID-19 Patent Pledge Deconstructing Moderna’s COVID-19 Patent Pledge
In the high-stakes market for COVID-19 vaccines, it is worth considering what motivates a private firm to relinquish valuable IP rights.
-
Read more: Patent Fakes: How Fraudulent Inventions Threaten Public Health, Innovation, and the Economy Patent Fakes: How Fraudulent Inventions Threaten Public Health, Innovation, and the Economy
What if you have a great idea for a new technology, but never actually create it, test it, or determine that it works? Is that patentable?
-
Read more: COVID-19 Highlights Need for Rights to Repair and Produce in Emergencies COVID-19 Highlights Need for Rights to Repair and Produce in Emergencies
The pandemic makes a stronger case for the need to explicitly incorporate into our legal system a right to repair and supply products in emergencies.
-
Read more: New TWIHL: Intellectual Property in the Time of COVID-19 New TWIHL: Intellectual Property in the Time of COVID-19
Our discussion probes broad questions regarding the role of intellectual property in promoting innovation and protecting against fakes during the pandemic.
-
Read more: Standards, Data Exchange and Intellectual Property Rights in Systems Biology Standards, Data Exchange and Intellectual Property Rights in Systems Biology
By Timo Minssen I am happy to announce that our recent paper on “Standards, Data Exchange and Intellectual Property Rights in Systems Biology” has been published in the Biotechnology Journal Vol 11, Issue 12, pp. 1477-1480. The paper was co-authored by Esther Van Zimmeren from the University of Antwerp, Berthold Rutz from the European Patent Office and me. Please…